Inipharm
PrivateLast Round
Series A
Nov 11, 2020
Total Funding Raised
$35M
Company Overview
Inipharm operates in Healthcare & Life Sciences and is based in Bellevue, Washington. Its latest recorded funding round was a Series A round in November 2020.
Inipharm is a biopharmaceutical company specializing in the discovery and development of small-molecule therapies for severe liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inipharm Comparables
Compare Inipharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therasid Bioscience | 84% | |
| Hepion Pharmaceuticals Inc | 78% | |
| Nula Therapeutics | 76% |
For institutional investors. Book with your work email.
Inipharm Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Inipharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Healthcare Partners | Series A |
| Wu Capital | Series A |
| 5AM Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 37% MoM.
For institutional investors. Book with your work email.
Inipharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inipharm's valuation, stock price, and market status.
Is Inipharm a public or private company?
Inipharm is a private company.
What is the current stock price of Inipharm?
Inipharm is a private company, so its shares have no public market price. Caplight tracks Inipharm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inipharm worth (valuation)?
Valuation information for Inipharm is not publicly available.
Can I buy Inipharm stock?
Inipharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inipharm's last funding round?
Inipharm's most recent funding round was Series A on November 11, 2020.
Who are the main investors in Inipharm?
Key investors in Inipharm include Frazier Healthcare Partners, Wu Capital, 5AM Ventures.
Will Inipharm IPO soon?
No public IPO plans have been announced for Inipharm.
How can I track Inipharm secondary market activity?
Caplight tracks bids, offers, and trades in Inipharm's shares on secondary markets.